Colleen Redlinger Tabery

Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.

W. Hwang, K. Reiss, S. Yee, 2022, JCO precision oncology.

A unique window of opportunity for practical reform of cancer clinical trials

R. Cohen, E. Meagher, R. Vonderheide, 2021, Cancer.